Vantage Investment Advisors, LLC - CARA THERAPEUTICS INC ownership

CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 136 filers reported holding CARA THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 1.82 and the average weighting 0.5%.

Quarter-by-quarter ownership
Vantage Investment Advisors, LLC ownership history of CARA THERAPEUTICS INC
ValueSharesWeighting
Q3 2018$29,000
+26.1%
1,2000.0%0.01%0.0%
Q2 2018$23,000
+35.3%
1,200
-11.1%
0.01%
+50.0%
Q1 2018$17,0000.0%1,3500.0%0.00%0.0%
Q4 2017$17,000
-26.1%
1,350
-20.6%
0.00%
-33.3%
Q3 2017$23,000
+27.8%
1,700
+41.7%
0.01%
+20.0%
Q2 2017$18,0000.0%1,200
+20.0%
0.01%
-16.7%
Q1 2017$18,0001,0000.01%
Other shareholders
CARA THERAPEUTICS INC shareholders Q2 2017
NameSharesValueWeighting ↓
RHO CAPITAL PARTNERS INC 3,568,057$70,005,00074.08%
Chescapmanager LLC 1,203,055$23,604,0002.80%
Mesirow Financial Investment Management, Inc. 29,821$585,0002.32%
DAFNA Capital Management LLC 143,611$2,818,0001.22%
Opaleye Management Inc. 200,000$3,924,0001.09%
SPHERA FUNDS MANAGEMENT LTD. 303,930$5,963,0000.54%
DISCIPLINED GROWTH INVESTORS INC /MN 852,892$16,734,0000.29%
DLD Asset Management, LP 352,700$6,927,0000.26%
SHANDA ASSET MANAGEMENT HOLDINGS Ltd 54,984$1,079,0000.18%
B. Riley Wealth Management, Inc. 33,755$662,0000.12%
View complete list of CARA THERAPEUTICS INC shareholders